PHOS-FAKE or PHOS-FATAL - Does intake of phosphate from foods lead to elevated plasma phosphate and its associated cardiovascular risks?

Clinical Nephrology

Volumn 74, Issue 1, 2010, Pages 1-3

  Davis, P A ^a   Savica, V ^b   Calo L A ^c  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF MESSINA   (Italy)

^c UNIVERSITY OF PADOVA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

FIBROBLAST GROWTH FACTOR 23; PHOSPHATE; BIOLOGICAL MARKER; CHELATING AGENT;

BLOOD VESSEL CALCIFICATION; CARDIOVASCULAR DISEASE; CHRONIC KIDNEY DISEASE; EDITORIAL; FOOD COMPOSITION; HEMODIALYSIS PATIENT; HUMAN; HYPERPHOSPHATEMIA; MORBIDITY; MORTALITY; PHOSPHATE BLOOD LEVEL; PHOSPHATE INTAKE; PROTEIN INTAKE; UREMIA; BLOOD; CARDIOVASCULAR DISEASES; COMPLICATION; DIET;

BIOLOGICAL MARKERS; CARDIOVASCULAR DISEASES; CHELATING AGENTS; DIET; HUMANS; HYPERPHOSPHATEMIA; PHOSPHATES;

EID: 77954743795     PISSN: 03010430     EISSN: None     Source Type: Journal    
DOI: 10.5414/cnp74001     Document Type: Editorial

References (15)

1. Calò LA, Savica V, Davis PA. Phosphorus in excess: a 'nutrient pollution' problem in the bloodbroken hearts like broken lakes (eutrophication)? Eur J Clin Nutr. 2009; 63: 1460.
2. Ganesh SK, Stack AG, Levin NW, Hulbert-Shearon T, Port FK. Association of elevated serum PO4, CaxPO4 product, and parathyroid hormone with cardiac mortality risk in chronic hemodialysis patients. J Am Soc Nephrol. 2001; 12: 2131-2138.
3. Kovesdy CP, Kalantar-Zadeh K. Bone and mineral disorders in pre-dialysis CKD. Int Urol Nephrol. 2008; 40: 427-440.
4. Dhingra, R, Sullivan LM, Fox CS, Wang TJ, D'Agostino RB Sr, Gaziano JM, Vasan RS. Relations of serum phosphorus and calcium levels to the incidence of cardiovascular disease in the community. Arch Intern Med. 2007; 167: 879-885. (Pubitemid 46762749)
5. Savica V, Calò LA, Monardo P, Santoro D, Bellinghieri G. Phosphate binders and management of hyperphosphataemia in end-stage renal disease. Nephrol Dial Transplant. 2006; 21: 2065-2068. (Pubitemid 44295028)
6. Young EW, Akiba T, Albert JM, McCarthy JT, Kerr PG, Mendelssohn DC, Jadoul M. Magnitude and impact of abnormal mineral metabolism in hemodialysis patients in the Dialysis Outcomes and Practice Patterns Study (DOPPS). Am J Kidney Dis. 2004; 44: 34-38.
7. De Boer IA, Tue TC, Kestenbaum B. Serum phosphorus concentration in the Third National Health and Nutrition Examination Survey (NHANES III). Am J Kidney Dis. 2009; 53: 399-407.
8. Goldstein-Fuchs J, Fouque D. The ubiquitous nature and elusive role of phosphorus and vascular calcification. Am J Kidney Dis. 2009; 53: 363-365.
9. Savica V, Calò LA, Monardo P, Caldarera R, Cavaleri A, Santoro D, Muraca U, Mallamace A, Bellinghieri G. High phosphate content beverages indialysis patients: relevance for hyperphosphatemia and cardiovascular risk. Nutr Metab Cardiovasc Dis. 2008; 18: e39-e40.
10. Sherman RA, Mehta O. Phosphorus and potassium content of enhanced meat and poultry products: implications for patients who receive dialysis. Clin J Am Soc Nephrol. 2009, 4: 1370-1373.
11. Shinaberger CS, Greenland S, Kopple JD, Van Wyck D, Mehrotra R, Kovesdy CP, Kalantar-Zadeh K. Is controlling phosphorus by decreasing dietary protein intake beneficial or harmful in persons with chronic kidney disease? Am J Clin Nutr. 2008; 88: 1511-1518.
12. Cianciolo G, La Manna G, Donati G, Persici E, Dormi A, Cappuccilli ML, Corsini S, Fattori R, Russo V, Nastasi V, Colì L, Wratten M, Stefoni S. Coronary calcifications in end-stage renal disease patients: A new link between osteoprotegerin, diabetes and body mass index? Blood Purif. 2010; 29: 13-22.
13. Roos M, Lutz J, Salmhofer H, Luppa P, Knauss A, Braun S, Martinof S, Schömig A, Heemann U, Kastrati A, Hausleiter J. Relation between plasma fibroblast growth factor-23, serum fetuin-A levels and coronary artery calcification evaluated by multislice computed tomography in patients with normal kidney function. Clin Endocrinol 2008; 68: 660-665.
14. Poslusna K, Ruprich J, de Vries JH, Jakubikova M, van't Veer P. Misreporting of energy and micro-nutrient in take estimated by food records and 24 hour recalls, control and adjustment methods in practice. Br J Nutr. 2009; 101 (Suppl 2): S73-S85.
15. Sprague SM, Ross EA, Nath SD, Zhang P, Pratt RD, Krause R. Lanthanum car bonate vs. sevelamer hydrochloride for the reduction of serum phosphorus in hemodialysis patients: a crossover study. Clin Nephrol. 2009; 72: 252-258.